KANEKO YASUNORI
Insider CIK 1277503 · COLL 10% owner · PRTO 10% owner · CNCE 10% owner · TTPH 10% owner · STRO 10% owner · DRNA 10% owner · ACRX 10% owner · SIBN 10% owner · RCUS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 16,900 | — | $0 | 16,900 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2026-06-11 | 2026-06-12 | 5,700 | — | $0 | 25,700 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 38,300 | — | $0 | 38,300 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2025-06-10 | 2025-06-12 | 13,300 | — | $0 | 33,300 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2025-02-27 | 2025-02-27 | 20,000 | $10.06 | $201.2K | 28,400 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 24,000 | — | $0 | 24,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2024-06-06 | 2024-06-07 | 8,400 | — | $0 | 15,200 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 19,500 | — | $0 | 19,500 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2023-06-15 | 2023-06-16 | 6,800 | — | $0 | 6,800 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 16,800 | — | $0 | 16,800 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2022-06-14 | 2022-06-16 | 4,100 | — | $0 | 4,100 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2021-06-03 | 2021-06-07 | 14,100 | — | $0 | 14,100 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2021-06-03 | 2021-06-07 | 3,000 | — | $0 | 6,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2021-04-23 | 2021-04-26 | 4,133 | $31.37 | $129.7K | 7,133 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | M Exercise deriv | 2020-06-05 | 2020-06-08 | 35,000 | — | $0 | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | M Exercise | 2020-06-05 | 2020-06-08 | 35,000 | $7.99 | $279.6K | 38,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2020-06-04 | 2020-06-08 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SIBN SI-BONE, Inc. | X Exercise deriv | 2018-10-19 | 2018-10-19 | 39,421 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | X Exercise deriv | 2018-10-19 | 2018-10-19 | 39,421 | — | $0 | 816,099 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale deriv | 2018-10-19 | 2018-10-19 | 23,904 | $14.00 | $334.7K | 792,195 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 2,213,425 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 792,195 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 652,347 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 398,676 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 792,195 | — | $0 | 3,005,620 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 2,213,425 | — | $0 | 2,213,425 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 690,689 | — | $0 | 3,696,309 | SEC↗ |
| SIBN SI-BONE, Inc. | P Buy | 2018-10-19 | 2018-10-19 | 325,000 | $15.00 | $4.88M | 4,419,985 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 398,676 | — | $0 | 4,094,985 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-03 | 18,698,578 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-03 | 12,846,023 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-03 | 25,015,635 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-03 | 925,578 | — | $0 | 925,578 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-03 | 520,264 | — | $0 | 1,445,842 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-03 | 514,211 | — | $0 | 1,960,053 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion deriv | 2018-03-19 | 2018-03-19 | 252,524 | — | $0 | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion deriv | 2018-03-19 | 2018-03-19 | 31,253 | — | $0 | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion deriv | 2018-03-19 | 2018-03-19 | 2,565 | — | $0 | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion deriv | 2018-03-19 | 2018-03-19 | 505,050 | — | $0 | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion | 2018-03-19 | 2018-03-19 | 33,818 | — | $0 | 96,948 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion | 2018-03-19 | 2018-03-19 | 505,050 | — | $0 | 505,050 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion | 2018-03-19 | 2018-03-19 | 252,524 | — | $0 | 252,524 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2017-12-05 | 2017-12-07 | 270 | — | $0 | 270 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2017-12-05 | 2017-12-07 | 800,000 | — | $0 | 2,149,916 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-13 | 5,881,724 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-13 | 2,638,030 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-13 | 10,714,286 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-13 | 382,323 | — | $0 | 1,935,118 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-13 | 864,798 | — | $0 | 2,799,916 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | P Buy | 2015-05-12 | 2015-05-13 | 150,000 | $12.00 | $1.80M | 2,949,916 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-13 | 1,552,795 | — | $0 | 1,552,795 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2015-02-20 | 2015-02-24 | 37,532 | $26.02 | $976.6K | 1,719,671 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,173,913 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,341,664 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 5,000,000 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,436,437 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 3,932,747 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2014-10-27 | 2014-10-29 | 1,389,064 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise deriv | 2014-10-27 | 2014-10-29 | 121,760 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-29 | 200,000 | $10.00 | $2.00M | 200,000 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 1,167,208 | — | $0 | 1,367,208 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise | 2014-10-27 | 2014-10-29 | 121,760 | $4.60 | $560.1K | 1,488,968 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | S Sale | 2014-10-27 | 2014-10-29 | 56,038 | $10.00 | $560.4K | 1,432,930 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2014-03-12 | 2014-03-14 | 4,493 | — | $0 | 4,493 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2014-03-12 | 2014-03-14 | 300,000 | — | $0 | 1,890,146 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2014-03-07 | 2014-03-11 | 1,300,000 | — | $0 | 2,871,933 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-20 | 2014-02-21 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-20 | 2014-02-21 | 2,200,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-20 | 2014-02-21 | 600,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-20 | 2014-02-21 | 150,000 | $14.00 | $2.10M | 1,208,920 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-20 | 2014-02-21 | 106,194 | — | $0 | 1,058,920 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-20 | 2014-02-21 | 530,974 | — | $0 | 952,726 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-20 | 2014-02-21 | 389,380 | — | $0 | 421,752 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 179,322 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 312,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 21,697 | — | $0 | 21,697 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 1,043,429 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 21,697 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 755 | — | $0 | 755 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-05 | 200,000 | $15.00 | $3.00M | 1,734,751 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 312,000 | — | $0 | 312,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 1,043,429 | — | $0 | 1,534,751 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 179,322 | — | $0 | 491,322 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 27,226,760 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,090,000 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,726,086 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 11,422,045 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 393,863 | — | $0 | 570,280 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 938,853 | — | $0 | 1,509,133 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2013-03-25 | 2013-03-27 | 681,012 | $7.00 | $4.77M | 2,190,145 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 94,003 | — | $0 | 176,417 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 72,069 | — | $0 | 82,414 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 256,228 | $0.13 | $33.3K | 256,228 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 284,698 | $3.40 | $968.0K | 4,161,933 | SEC↗ |